Selected research
Industry Research
Etoposide Industry Research Report 2026
Market perspective
The global Etoposide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Etoposide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Etoposide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Etoposide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Etoposide include Teva Pharmaceutical, Qilu Antibiotics, Mylan, China Resources Double Crane Pharmaceutical, Shyndec Pharmaceutical, Nippon Kayaku, KPC Pharmaceuticals, Gansu Fuzheng and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Etoposide market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Etoposide Market by Company
Teva Pharmaceutical
Qilu Antibiotics
Mylan
China Resources Double Crane Pharmaceutical
Shyndec Pharmaceutical
Nippon Kayaku
KPC Pharmaceuticals
Gansu Fuzheng
Accord Healthcare
Etoposide Segment by Type
Etoposide for Injection
Etoposide for Oral Use
Etoposide Segment by Application
Small Cell Lung Cancer
Testicular Cancer
Etoposide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etoposide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Etoposide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etoposide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Etoposide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Etoposide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Etoposide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Etoposide for Injection
- Etoposide for Oral Use
Applications
- Small Cell Lung Cancer
- Testicular Cancer
Companies covered
- Teva Pharmaceutical
- Qilu Antibiotics
- Mylan
- China Resources Double Crane Pharmaceutical
- Shyndec Pharmaceutical
- Nippon Kayaku
- KPC Pharmaceuticals
- Gansu Fuzheng
- Accord Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Etoposide Market Size (2021-2032)
- 2.2.2 Global Etoposide Sales (2021-2032)
- 2.2.3 Global Etoposide Market Average Price (2021-2032)
- 2.3 Etoposide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Etoposide for Injection
- 2.3.3 Etoposide for Oral Use
- 2.4 Etoposide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Small Cell Lung Cancer
- 2.4.3 Testicular Cancer
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Etoposide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Etoposide Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Etoposide Revenue of Manufacturers (2021-2026)
- 3.4 Global Etoposide Average Price by Manufacturers (2021-2026)
- 3.5 Global Etoposide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Etoposide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Etoposide, Product Type & Application
- 3.8 Global Manufacturers of Etoposide, Established Date
- 3.9 Global Etoposide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Etoposide Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Qilu Antibiotics
- 4.2.1 Qilu Antibiotics Company Information
- 4.2.2 Qilu Antibiotics Business Overview
- 4.2.3 Qilu Antibiotics Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qilu Antibiotics Etoposide Product Portfolio
- 4.2.5 Qilu Antibiotics Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Etoposide Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 China Resources Double Crane Pharmaceutical
- 4.4.1 China Resources Double Crane Pharmaceutical Company Information
- 4.4.2 China Resources Double Crane Pharmaceutical Business Overview
- 4.4.3 China Resources Double Crane Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 China Resources Double Crane Pharmaceutical Etoposide Product Portfolio
- 4.4.5 China Resources Double Crane Pharmaceutical Recent Developments
- 4.5 Shyndec Pharmaceutical
- 4.5.1 Shyndec Pharmaceutical Company Information
- 4.5.2 Shyndec Pharmaceutical Business Overview
- 4.5.3 Shyndec Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shyndec Pharmaceutical Etoposide Product Portfolio
- 4.5.5 Shyndec Pharmaceutical Recent Developments
- 4.6 Nippon Kayaku
- 4.6.1 Nippon Kayaku Company Information
- 4.6.2 Nippon Kayaku Business Overview
- 4.6.3 Nippon Kayaku Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nippon Kayaku Etoposide Product Portfolio
- 4.6.5 Nippon Kayaku Recent Developments
- 4.7 KPC Pharmaceuticals
- 4.7.1 KPC Pharmaceuticals Company Information
- 4.7.2 KPC Pharmaceuticals Business Overview
- 4.7.3 KPC Pharmaceuticals Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 KPC Pharmaceuticals Etoposide Product Portfolio
- 4.7.5 KPC Pharmaceuticals Recent Developments
- 4.8 Gansu Fuzheng
- 4.8.1 Gansu Fuzheng Company Information
- 4.8.2 Gansu Fuzheng Business Overview
- 4.8.3 Gansu Fuzheng Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gansu Fuzheng Etoposide Product Portfolio
- 4.8.5 Gansu Fuzheng Recent Developments
- 4.9 Accord Healthcare
- 4.9.1 Accord Healthcare Company Information
- 4.9.2 Accord Healthcare Business Overview
- 4.9.3 Accord Healthcare Etoposide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Accord Healthcare Etoposide Product Portfolio
- 4.9.5 Accord Healthcare Recent Developments
5 Global Etoposide Market Scenario by Region
- 5.1 Global Etoposide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Etoposide Sales by Region: 2021-2032
- 5.2.1 Global Etoposide Sales by Region: 2021-2026
- 5.2.2 Global Etoposide Sales by Region: 2027-2032
- 5.3 Global Etoposide Revenue by Region: 2021-2032
- 5.3.1 Global Etoposide Revenue by Region: 2021-2026
- 5.3.2 Global Etoposide Revenue by Region: 2027-2032
- 5.4 North America Etoposide Market Facts & Figures by Country
- 5.4.1 North America Etoposide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Etoposide Sales by Country (2021-2032)
- 5.4.3 North America Etoposide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Etoposide Market Facts & Figures by Country
- 5.5.1 Europe Etoposide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Etoposide Sales by Country (2021-2032)
- 5.5.3 Europe Etoposide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Etoposide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Etoposide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Etoposide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Etoposide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Etoposide Market Facts & Figures by Country
- 5.7.1 South America Etoposide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Etoposide Sales by Country (2021-2032)
- 5.7.3 South America Etoposide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Etoposide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Etoposide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Etoposide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Etoposide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Etoposide Sales by Type (2021-2032)
- 6.1.1 Global Etoposide Sales by Type (2021-2032) & (units)
- 6.1.2 Global Etoposide Sales Market Share by Type (2021-2032)
- 6.2 Global Etoposide Revenue by Type (2021-2032)
- 6.2.1 Global Etoposide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Etoposide Revenue Market Share by Type (2021-2032)
- 6.3 Global Etoposide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Etoposide Sales by Application (2021-2032)
- 7.1.1 Global Etoposide Sales by Application (2021-2032) & (units)
- 7.1.2 Global Etoposide Sales Market Share by Application (2021-2032)
- 7.2 Global Etoposide Revenue by Application (2021-2032)
- 7.2.1 Global Etoposide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Etoposide Revenue Market Share by Application (2021-2032)
- 7.3 Global Etoposide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Etoposide Value Chain Analysis
- 8.1.1 Etoposide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Etoposide Production Mode & Process
- 8.2 Etoposide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Etoposide Distributors
- 8.2.3 Etoposide Customers
9 Global Etoposide Analyzing Market Dynamics
- 9.1 Etoposide Industry Trends
- 9.2 Etoposide Industry Drivers
- 9.3 Etoposide Industry Opportunities and Challenges
- 9.4 Etoposide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst